San Francisco, January 16, 2023 /PR Newswire/ — bottleis a technology-enabled CRO that provides next-generation clinical trial management services, Stewart J. TepperMD, FAHS, as their new CNS Scientific Advisor Neurology CRO.
“We are delighted to welcome Dr. Tepper to our CNS SAB and are grateful for his scientific contributions as we continue to expand our Neurology CRO.” Simon BurnsCEO and co-founder of Vial.
Vial is committed to providing biotech sponsors with faster, more efficient clinical trials at up to 50% cost savings.vial Neurology CRO We differentiate ourselves by leveraging digital technologies such as the Vial Technology Platform. e source, EDCWhen ePRO into one connected system to streamline processes on the shop floor. These best-in-class his CRO services accelerate the development of new therapies and devices for neurology sponsors and patients.
“I am very interested in improving the quality of clinical trials through optimal and creative structural and process improvements involving sponsors, clinical research sites, patients and sites,” said Dr. Tepper. says.
Dr. Tepper is a neurologist, professor of neurology, and certified expert in headache medications at Dartmouth-Hitchcock Medical Center in the United States. Lebanon, New HampshireHe was trained in medicine Cornell University Completed a neurology residency in medical school harvardDr. Tepper has contributed to over 460 peer-reviewed publications, co-authored eight books, and led numerous clinical trials in neurology. His recent research focuses on new headache treatments based on both pharmaceuticals and devices. Dr. Tepper serves on the Board of Directors of the American Headache Society and the Board of Directors of the American Migraine Foundation.
For more information on vials, please visit: our website.
See full release here.
About vials: bottle is a next-generation, technology-enabled CRO that promises faster, higher-quality clinical trials.of Vial Contract Research Organization (CRO) promises more efficient trials through an innovative technology platform that powers trials end-to-end from site launch to database lock. The key to Vial’s tech-enabled platform is Vial’s modern, intuitive electronic source And it’s a powerful tool for CRA that allows for considerable efficiency. Vials work in multiple treatment areas (Dermatology CRO, Ophthalmology CRO, Oncology CRO, Gastroenterology CRO, Neurology CROWhen Cardiology CRO).the vial is San Francisco, CaliforniaOver 125 employees.